Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James L Kelley

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
International Review of Psychiatry (Abingdon, England)|January 29, 2020
Outline for a future psychiatry: the transcendent meaning model (TMM)James L Kelley
International Review of Psychiatry (Abingdon, England)|January 6, 2023
Contact: William S. Burroughs's philosophy of loveJames L Kelley
International Review of Psychiatry (Abingdon, England)|September 19, 2025
Fourth industrial revolutionary: an attachment-theoretical approach to the life and career of Elon MuskJames L Kelley
Annual Reports in Medicinal Chemistry|April 28, 2020
Chapter 12. Antiviral AgentsJames L Kelley
Europe'S Journal of Psychology|February 9, 2022
The Emperor of Fashion's New Starts: Creativity and Meaning in Life in Karl LagerfeldClaude-Hélène Mayer, James L Kelley
Organic & Biomolecular Chemistry|August 21, 2003
Novel 3-phenylprop-2-ynylamines as inhibitors of mammalian squalene epoxidaseDavid L Musso, Morris J Clarke, James L Kelley, et al.
Journal of Medicinal Chemistry|January 24, 2003
Indanylidenes. 2. Design and synthesis of (E)-2-(4-chloro-6-fluoro-1-indanylidene)-N-methylacetamide, a potent antiinflammatory and analgesic agent without centrally acting muscle relaxant activityDavid L Musso, G Faye Orr, Felicia R Cochran, et al.
Journal of Medicinal Chemistry|January 24, 2003
Indanylidenes. 1. Design and synthesis of (E)-2-(4,6-difluoro-1-indanylidene)acetamide, a potent, centrally acting muscle relaxant with antiinflammatory and analgesic activityDavid L Musso, Felicia R Cochran, James L Kelley, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
International Review of Psychiatry (Abingdon, England)|January 29, 2020
Outline for a future psychiatry: the transcendent meaning model (TMM)James L Kelley
International Review of Psychiatry (Abingdon, England)|January 6, 2023
Contact: William S. Burroughs's philosophy of loveJames L Kelley
International Review of Psychiatry (Abingdon, England)|September 19, 2025
Fourth industrial revolutionary: an attachment-theoretical approach to the life and career of Elon MuskJames L Kelley
Annual Reports in Medicinal Chemistry|April 28, 2020
Chapter 12. Antiviral AgentsJames L Kelley
Europe'S Journal of Psychology|February 9, 2022
The Emperor of Fashion's New Starts: Creativity and Meaning in Life in Karl LagerfeldClaude-Hélène Mayer, James L Kelley
Organic & Biomolecular Chemistry|August 21, 2003
Novel 3-phenylprop-2-ynylamines as inhibitors of mammalian squalene epoxidaseDavid L Musso, Morris J Clarke, James L Kelley, et al.
Journal of Medicinal Chemistry|January 24, 2003
Indanylidenes. 2. Design and synthesis of (E)-2-(4-chloro-6-fluoro-1-indanylidene)-N-methylacetamide, a potent antiinflammatory and analgesic agent without centrally acting muscle relaxant activityDavid L Musso, G Faye Orr, Felicia R Cochran, et al.
Journal of Medicinal Chemistry|January 24, 2003
Indanylidenes. 1. Design and synthesis of (E)-2-(4,6-difluoro-1-indanylidene)acetamide, a potent, centrally acting muscle relaxant with antiinflammatory and analgesic activityDavid L Musso, Felicia R Cochran, James L Kelley, et al.
Pageof 1